New eye ointment aimed at soothing chronic eyelid inflammation
Disease control
Terminated
This study tested a medicated ointment called pimecrolimus 0.3% for people with blepharitis, a condition that causes red, irritated eyelids. The trial planned to include 477 participants aged 2 and older, applying the ointment twice daily to the eyelid margins. The main goal was …
Phase: PHASE3 • Sponsor: Famy Life Sciences, a Viatris Company • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC